Subdirect

Subdirect, LLC provides loyalty-building solutions that enable companies to offer premium publisher titles to help brands connect to their audiences. Its solutions range from campaign development to fulfillment and CRM technologies to large and small businesses. Subdirect’s customers include local and national leaders in ecommerce, brick-and-mortar retail, and charitable programs. In 2013, Subdirect became an official partner of Susan G. Komen as the proud presenter of the Read for the Cure® program which started in 2007.

In addition to the traditional Read for the Cure program, Subdirect is recently announced the release of the brand new Read for the Cure app. Through this app, Read for the Cure gives readers access to leading magazines via iPhone, iPad, and iPod touch while supporting Komen in the fight against breast cancer. Click here for more information.

Programs

Read for the Cure®

Since 2007, the Read for the Cure® program has offered readers the opportunity to purchase magazine subscriptions at discounted prices all benefiting Susan G. Komen. From January 1 through December 31, 2016, Subdirect will donate 10% of the retail price for each subscription sold through direct mail and 20% of the retail price for each subscription sold online at myreadforthecure.com with a guaranteed minimum donation of $200,000.

[No File Selected]

* By submitting your story and original photo, you agree to the Terms of Use, including the terms for posted content, and our Privacy Policy, and the official rules to the contest
/ Al enviar tu historia y foto original, aceptas nuestros Términos de uso, incluidos los términos de contenido publicado y nuestra política de privacidad, y las reglas oficiales del concurso.

Would you like to be contacted by Komen for future marketing purposes? / ¿Quisieras ser contactado por Komen para recibir material de marketing?

Products

“We are proud to support Susan G. Komen® through Read for the Cure®. Read for the Cure® has raised over $2 million dollars through magazine sales and every day our team is inspired to help in the mission to save lives and end breast cancer forever.”

Kelly Vucovich, CEO and Co-Founder, Subdirect

Partner Channels

Champion Partner

Subdirect

Partner Since

2013

Total Contributions

$481K+

Minimum Donation

$200K

Read for the Cure®

Active Program Dates:January 2016 through December 2016

Product:Magazine subscriptions benefiting Susan G. Komen

Product Available for Purchase:Through direct mail offers, online at www.myreadforthecure.com and through the Read for the Cure app.

Benefit to Komen:At least 10% of each magazine subscription ordered through direct mail and 20% of each magazine subscription ordered online and through the Read for the Cure app

In addition to the traditional Read for the Cure program, Subdirect recently announced the release of the new Read for the Cure app. Through this app, Read for the Cure gives readers access to leading magazines via iPhone, iPad, and iPod touch while supporting Komen in the fight against breast cancer. Subdirect will donate to Komen 20 percent of the retail price of each subscription purchased through the app through December 31, 2016. All donations will be applied to Subdirect's aggregate guaranteed minimum donation of $200,000 for 2016. More information about the new Read for the Cure app is available here.

Find more information about Komen's partnership with Subdirect and the Read for the Cure program.

Our corporate partners and sponsors are passionate about their involvement with us, engaging their customers, employees and communities in our mission to save lives and end breast cancer. Through their generosity, we educate millions of women and families about breast cancer and raise crucial funds for breast cancer research, education, screening and treatment. We strive to serve as a valuable nonprofit partner by developing partnerships that are beneficial for the consumer, the company and for our mission.

Help us spread the word!

Show your support of our partners working toward Komen's mission of ending breast cancer.